loadpatents
Patent applications and USPTO patent grants for MURALI; Ramachandran.The latest application filed is for "compositions and methods for treating cancer and autoimmune diseases".
Patent | Date |
---|---|
Compositions And Methods For Treating Cancer And Autoimmune Diseases App 20210299176 - MURALI; Ramachandran ;   et al. | 2021-09-30 |
Compositions And Methods For Treating Cancers App 20210276964 - Edderkaoui; Mouad ;   et al. | 2021-09-09 |
Compositions And Methods For Treating Cancer App 20210163403 - FREEMAN; Michael ;   et al. | 2021-06-03 |
Methods And Use Of Compounds That Bind To Rela Of Nf-kb App 20210085649 - MURALI; Ramachandran ;   et al. | 2021-03-25 |
Compositions and methods for treating cancer Grant 10,927,070 - Freeman , et al. February 23, 2 | 2021-02-23 |
Methods and use of compounds that bind to RelA of NF-kB Grant 10,881,641 - Murali , et al. January 5, 2 | 2021-01-05 |
Compositions and methods for treating cancers Grant 10,836,735 - Edderkaoui , et al. November 17, 2 | 2020-11-17 |
Compositions And Methods For Treating Cancer App 20200188373 - FREEMAN; Michael ;   et al. | 2020-06-18 |
Antigen-binding proteins comprising recombinant protein scaffolds Grant 10,583,166 - Greene , et al. | 2020-03-10 |
Compositions And Methods For Treating Cancer App 20190194124 - FREEMAN; Michael ;   et al. | 2019-06-27 |
Compositions And Methods For Treating Cancers App 20190194152 - Edderkaoui; Mouad ;   et al. | 2019-06-27 |
Compositions And Methods For Treating Fibrosis App 20190183967 - Murali; Ramachandran ;   et al. | 2019-06-20 |
Compositions and methods for treating cancers Grant 10,266,505 - Edderkaoui , et al. | 2019-04-23 |
Compositions and methods for treating fibrosis Grant 10,245,298 - Murali , et al. | 2019-04-02 |
Compositions And Methods For Treating Cancers App 20180297965 - Edderkaoui; Mouad ;   et al. | 2018-10-18 |
Compositions and methods for treating cancers Grant 10,029,997 - Edderkaoui , et al. July 24, 2 | 2018-07-24 |
Methods And Use Of Compounds That Bind To Rela Of Nf-kb App 20180078528 - Murali; Ramachandran ;   et al. | 2018-03-22 |
Compositions And Methods Of Treating Tumors App 20170355778 - GREENE; Mark I. ;   et al. | 2017-12-14 |
Inhibitors of the tumor necrosis factor receptor complex Grant 9,751,830 - Murali , et al. September 5, 2 | 2017-09-05 |
Antigen-Binding Proteins Comprising Recombinant Protein Scaffolds App 20170239324 - Greene; Mark I. ;   et al. | 2017-08-24 |
Compositions And Methods For Treating Fibrosis App 20170189471 - Murali; Ramachandran ;   et al. | 2017-07-06 |
Antigen-binding proteins comprising recombinant protein scaffolds Grant 9,695,252 - Greene , et al. July 4, 2 | 2017-07-04 |
Compositions And Methods For Treating Cancers App 20170121297 - Edderkaoui; Mouad ;   et al. | 2017-05-04 |
Compositions and Methods of Treating Tumors App 20160289334 - Greene; Mark I. ;   et al. | 2016-10-06 |
Compositions and Methods of Treating Tumors App 20160083478 - Greene; Mark I. ;   et al. | 2016-03-24 |
Methods and use of compounds that bind to HER2/neu receptor complex Grant 9,265,739 - Greene , et al. February 23, 2 | 2016-02-23 |
Inhibitors Of The Tumor Necrosis Factor Receptor Complex App 20150368187 - Murali; Ramachandran ;   et al. | 2015-12-24 |
Tumor necrosis factor inhibitors Grant 9,096,607 - Greene , et al. August 4, 2 | 2015-08-04 |
Methods and use of compounds that bind to Her2/neu receptor complex Grant 8,993,634 - Greene , et al. March 31, 2 | 2015-03-31 |
ErbB interface peptidomimetics and methods of use thereof Grant 8,962,793 - Greene , et al. February 24, 2 | 2015-02-24 |
Compositions and Methods of Treating Tumors App 20150010551 - Greene; Mark I. ;   et al. | 2015-01-08 |
Methods and compositions targeting viral and cellular ITAM motifs, and use of same in identifying compounds with therapeutic activity Grant 8,859,503 - Monroe , et al. October 14, 2 | 2014-10-14 |
Tumor Necrosis Factor Inhibitors App 20140256803 - GREENE; MARK I. ;   et al. | 2014-09-11 |
Antigen-binding Proteins Comprising Recombinant Protein Scaffolds App 20140234221 - Greene; Mark I. ;   et al. | 2014-08-21 |
Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same Grant 8,785,419 - Murali , et al. July 22, 2 | 2014-07-22 |
Tumor necrosis factor inhibitors Grant 8,765,810 - Greene , et al. July 1, 2 | 2014-07-01 |
Antigen-binding proteins comprising recombinant protein scaffolds Grant 8,728,479 - Greene , et al. May 20, 2 | 2014-05-20 |
Method of treating cancer using a survivin inhibitor Grant 8,710,068 - Berezov , et al. April 29, 2 | 2014-04-29 |
Fas peptide mimetics and uses thereof Grant 8,680,047 - Greene , et al. March 25, 2 | 2014-03-25 |
Rel Inhibitors And Methods Of Use Thereof App 20140066486 - CHEN; Youhai H. ;   et al. | 2014-03-06 |
Rel inhibitors and methods of use thereof Grant 8,609,730 - Chen , et al. December 17, 2 | 2013-12-17 |
Erbb Interface Peptidomimetics And Methods Of Use Thereof App 20130217857 - Greene; Mark I. ;   et al. | 2013-08-22 |
Compositions and Methods of Treating Tumors App 20130204069 - Greene; Mark I. ;   et al. | 2013-08-08 |
Methods And Use Of Compounds That Bind To Her2/neu Receptor Complex App 20130190405 - Greene; Mark I. ;   et al. | 2013-07-25 |
Methods And Use Of Compounds That Bind To Her2/neu Receptor Complex App 20130137774 - Greene; Mark I. ;   et al. | 2013-05-30 |
ErbB interface peptidomimetics and methods of use thereof Grant 8,445,644 - Greene , et al. May 21, 2 | 2013-05-21 |
Tumor Necrosis Factor Inhibitors App 20130072562 - GREENE; MARK I. ;   et al. | 2013-03-21 |
Tumor necrosis factor inhibitors Grant 8,318,699 - Greene , et al. November 27, 2 | 2012-11-27 |
Fas Peptide Mimetics And Uses Thereof App 20120245081 - Greene; Mark I. ;   et al. | 2012-09-27 |
Antigen-binding Proteins Comprising Recombinant Protein Scaffolds App 20120164066 - Greene; Mark I. ;   et al. | 2012-06-28 |
Method Of Treating Cancer Using A Survivin Inhibitor App 20120122910 - Berezov; Alan ;   et al. | 2012-05-17 |
Receptor Activator Of The Rank Receptor Complex Inhibitor App 20120108559 - Murali; Ramachandran ;   et al. | 2012-05-03 |
Compositions And Methods Of Treating Tumors App 20120014965 - Greene; Mark I. ;   et al. | 2012-01-19 |
Cavity Induced Allosteric Modification Of Intermolecular Interactions And Methods Of Identifying Compounds That Effect The Same App 20110312920 - Murali; Ramachandran ;   et al. | 2011-12-22 |
ErbB interface peptidomimetics and methods of use thereof Grant 8,057,799 - Greene , et al. November 15, 2 | 2011-11-15 |
FAS peptide mimetics and uses thereof Grant 8,022,176 - Greene , et al. September 20, 2 | 2011-09-20 |
Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same Grant 8,019,557 - Murali , et al. September 13, 2 | 2011-09-13 |
Methods of inhibiting osteoclast activity Grant 8,003,628 - Greene , et al. August 23, 2 | 2011-08-23 |
Compounds that bind to p185 and methods of using the same Grant 7,998,924 - Greene , et al. August 16, 2 | 2011-08-16 |
Rel Inhibitors And Methods Of Use Thereof App 20110118325 - Chen; Youhai H. ;   et al. | 2011-05-19 |
Binding peptidomimetics and uses of the same Grant 7,906,624 - Greene , et al. March 15, 2 | 2011-03-15 |
Compounds That Bind To P185 And Methods Of Using The Same App 20100311669 - Greene; Mark I. ;   et al. | 2010-12-09 |
ErbB Interface Peptidomimetics And Methods Of Use Thereof App 20100239587 - Greene; Mark I. ;   et al. | 2010-09-23 |
ErbB interface peptidomimetics and methods of use thereof Grant 7,781,566 - Greene , et al. August 24, 2 | 2010-08-24 |
Monoclonal Antibodies To Activated Erbb Family Members And Methods Of Use App 20100189649 - Greene; Mark I. ;   et al. | 2010-07-29 |
Compounds that bind to P185 and methods of using the same Grant 7,745,577 - Greene , et al. June 29, 2 | 2010-06-29 |
Cavity Induced Allosteric Modification Of Intermolecular Interactions And Methods Of Identifying Compounds That Effect The Same App 20100151507 - MURALI; Ramachandran ;   et al. | 2010-06-17 |
ErbB Interface Peptidomimetics And Methods Of Use Thereof App 20100120688 - Greene; Mark I. ;   et al. | 2010-05-13 |
ErbB Interface Peptidomimetics And Methods Of Use Thereof App 20100076174 - Greene; Mark I. ;   et al. | 2010-03-25 |
Monoclonal antibodies to activated erbB family members and methods of use thereof Grant 7,662,374 - Greene , et al. February 16, 2 | 2010-02-16 |
Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same Grant 7,653,495 - Murali , et al. January 26, 2 | 2010-01-26 |
ErbB interface peptidomimetics and methods of use thereof Grant 7,638,598 - Greene , et al. December 29, 2 | 2009-12-29 |
Methods Of Inhibiting Osteoclast Activity App 20090306030 - Greene; Mark I. ;   et al. | 2009-12-10 |
Compositions and methods of treating tumors Grant 7,625,558 - Greene , et al. December 1, 2 | 2009-12-01 |
Erbb Interface Peptidomimetics And Methods Of Use Thereof App 20090286737 - Greene; Mark I. ;   et al. | 2009-11-19 |
Methods And Compositions Targeting Viral And Cellular Itam Motifs, And Use Of Same In Identifying Compounds With Therapeutic Activity App 20090258032 - MONROE; John G. ;   et al. | 2009-10-15 |
Tumor Necrosis Factor Inhibitors App 20090221527 - Greene; Mark I. ;   et al. | 2009-09-03 |
Methods of inhibiting osteoclast activity Grant 7,566,741 - Greene , et al. July 28, 2 | 2009-07-28 |
Compositions and Methods of Treating Tumors App 20090010935 - Greene; Mark I. ;   et al. | 2009-01-08 |
Binding Peptidomimetics and Uses of the Same App 20080206136 - Greene; Mark I. ;   et al. | 2008-08-28 |
Fas Peptide Mimetics And Uses Thereof App 20080153742 - Greene; Mark I. ;   et al. | 2008-06-26 |
Fas peptide mimetics and uses thereof Grant 7,288,519 - Greene , et al. October 30, 2 | 2007-10-30 |
Compounds that bind to P185 and methods of using the same App 20070207086 - Greene; Mark I. ;   et al. | 2007-09-06 |
Methods and compositions targeting viral and cellular ITAM motifs, and use of same in identifying compounds with therapeutic activity App 20070110760 - Monroe; John G. ;   et al. | 2007-05-17 |
Compounds that bind to p185 and methods of using the same Grant 7,179,785 - Greene , et al. February 20, 2 | 2007-02-20 |
Monoclonal antibodies to activated erbB family members and methods of use thereof App 20060073140 - Greene; Mark I. ;   et al. | 2006-04-06 |
Methods of inhibiting osteoclast activity App 20050080133 - Greene, Mark I. ;   et al. | 2005-04-14 |
Fas peptide mimetics and uses thereof App 20040132641 - Greene, Mark I. ;   et al. | 2004-07-08 |
Tyrosine kinase inhibitors and methods of using the same Grant 6,740,665 - Murali , et al. May 25, 2 | 2004-05-25 |
Methods of inhibiting osteoclastogenesis Grant 6,682,739 - Greene , et al. January 27, 2 | 2004-01-27 |
Methods of inhibiting osteoclast activity Grant 6,673,771 - Greene , et al. January 6, 2 | 2004-01-06 |
Compounds that bind to p185 and methods of using the same App 20030148932 - Greene, Mark I. ;   et al. | 2003-08-07 |
Compositions and methods of treating tumors App 20020165193 - Greene, Mark I. ;   et al. | 2002-11-07 |
Compositions and methods of treating tumors Grant 6,417,168 - Greene , et al. July 9, 2 | 2002-07-09 |
Peptides and peptide analogues designed from binding sites of tumor necrosis factor receptor superfamily and their uses Grant 6,265,535 - Greene , et al. July 24, 2 | 2001-07-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.